RTRX Stock Price, News & Analysis

RTRX NASDAQ

Company Description

RTRX (NASDAQ: RTRX) is a publicly traded biotechnology company in the Health Technology sector.

RTRX stock has gained 86.3% over the past year.

This page provides a comprehensive overview of RTRX stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart

$—

0.00%

0.00

Last updated:

+86.32%

Performance 1 year

$0.0

Market Cap

0.0

Shares outstanding

RTRX (RTRX) stock. Over the past 12 months, the stock has gained 86.3%.

Latest News

View All

November 30, 2020

—

Travere Therapeutics Announces Completion of Patient Enrollment in Pivotal Phase 3 DUPLEX Study of Sparsentan in Focal Segmental Glomerulosclerosis

clinical trial

November 16, 2020

+1.82%

Retrophin Announces Corporate Name Change to Travere Therapeutics, Inc.

November 12, 2020

+0.64%

Retrophin Completes Acquisition of Orphan Technologies

acquisition

November 11, 2020

-1.96%

Retrophin to Present at Upcoming Investor Conferences

conferences

November 5, 2020

+3.30%

Retrophin Reports Third Quarter 2020 Financial Results

earnings

October 22, 2020

-0.62%

Retrophin Announces Agreement to Acquire Orphan Technologies

acquisition

RTRX has 10 recent news articles. Of the recent coverage, 4 articles coincided with positive price movement and 5 with negative movement. Key topics include clinical trial, acquisition, conferences, earnings. View all RTRX news →

SEC Filings

View All

No SEC filings available for RTRX.

Financial Highlights

View Full Financials

—

Revenue (TTM)

—

Net Income (TTM)

—

Diluted EPS (TTM)

—

Operating Cash Flow

—

Net Profit Margin

—

Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months

RTRX Company Profile & Sector Positioning

RTRX (RTRX) operates in the Biotechnology industry within the broader Health Technology sector and is listed on the NASDAQ.